Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CCM Research Issues Update Report on Starpharma Holdings Ltd.

Abstract:
CCM Research analyst, Mohammad Sharifzadeh, Ph.D., CFA, has written an update report on Starpharma Holdings Ltd.

CCM Research Issues Update Report on Starpharma Holdings Ltd.

New York, NY | Posted on October 29th, 2007

Starpharma Holdings, Ltd. (OTCQX: SPHRY) (ASX: SPL) is an Australian-based company engaged in the development and application of dendrimer nanotechnologies as drugs and in other life science applications. Starpharma's business strategy is to use dendrimer-based nanotechnology to discover, develop and commercialize pharmaceuticals for serious human diseases and in life sciences.

In the report the analyst states "with the increasing global awareness of the HIV/AIDS problem and the accelerating endeavors at the international, governmental, civil social groups, and even individuals' levels to prevent and treat this devastating epidemic as quick as possible, Starpharma's VivaGel stands at the forefront of the global HIV/AIDS prevention strategies."

The analyst continues "we agree with Starpharma's management that acquisition of DNT results in valuable synergies including more U.S. presence, extensive IP portfolio, road to commercialization, and a more diversified product base."

Regarding Starpharma's external financing the analyst notes, "They have a strong cash position which can support their operating and R&D expenses should there be a shortfall in revenues. Starpharma has almost a debt free balance sheet with substantial equity which provides the company with the opportunity of external financing should the need arises."

A free copy of the report can be found at http://www.ccmopportunitybase.com .

CCM Research, a division of Cronus Capital Markets, Inc. subscribes to the "Standards for Independent Research Providers" and the principles contained in the Analyst/Corporate Issuer Guidelines jointly promulgated by the CFA Institute and the National Investor Relations Institute, described at: http://www.cfainstitute.org and http://www.niri.org .

Cronus Capital Markets, Inc., through its CCM Consulting Division, entered into a one year $30,000.00 contract with the company to assist it with the creation and execution of information-based strategies to overcome market inefficiencies that are commonplace for the vast majority of public companies, including share illiquidity and stagnant market capitalization.

####

About Cronus Capital Markets
Cronus Capital Markets (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. CCM's equity indexes receive international attention and represent important new benchmarks of growth.

For more information, please click here

Contacts:
Cronus Capital Markets
Dianne Rudderham
Program Director
(416) 368-3700 ext 223
Email:

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanometrics Announces Upcoming Investor Events August 3rd, 2017

Nanometrics to Participate in the 9th Annual CEO Investor Summit 2017: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2017 in San Francisco June 27th, 2017

Nanomedicine

Nanobiotix completes patient inclusion for Phase II/III trial of NBTXR3 in soft tissue sarcoma October 23rd, 2017

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting(R) 2017 October 23rd, 2017

Spinning strands hint at folding dynamics: Rice University lab uses magnetic beads to model microscopic proteins, polymers October 17th, 2017

Announcements

Picosun’s ALD nanolaminates improve lifetime and reliability of electronic circuit boards October 24th, 2017

JPK reports the research of the Schwille Group at the Max Planck Institute of Biochemistry near Munich using the NanoWizard® ULTRA Speed AFM October 24th, 2017

GTC Shanghai Highlights GF’s Momentum in China: Company shares details of technology roadmap and customer adoption in the world’s fastest-growing market for semiconductors October 23rd, 2017

Nanobiotix completes patient inclusion for Phase II/III trial of NBTXR3 in soft tissue sarcoma October 23rd, 2017

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Nanotube fiber antennas as capable as copper: Rice University researchers show their flexible fibers work well but weigh much less October 23rd, 2017

A step closer to understanding quantum mechanics: Swansea University’s physicists develop a new quantum simulation protocol October 22nd, 2017

Creation of coherent states in molecules by incoherent electrons October 21st, 2017

Strange but true: turning a material upside down can sometimes make it softer October 20th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project